Successful 2022 Milestones Support Value of Gb Sciences' AI-

Biopharmaceutical research company specializing in cannabis- and plant-inspired medicines shares strategic plan for 2023 and key developments from 2022LAS VEGAS, NV / ACCESSWIRE / March 7, 2023 / Gb Sciences

Related Keywords

Canada , United Kingdom , Canadian , Catalent Pharma , Dennis Riedl , Catalent Pharma Zydis , Contract Research Organization , University Of Lethbridge , Michigan State University , National Research Council Of Canada , Contract Research Organizations , Exchange Commission , National Research Council , Covance , Gb Sciences , Labcorp Drug Development , Gb Sciences Inc , Gbs Global Biopharma Inc , Chief Science Officer , Andrea Small Howard , Drug Discovery , Advanced Heart Disease , Chronic Pain , Discovery Platform , Minimal Essential Mixtures , Investigational New Drug , Orally Disintegrating Tablet , Chemistry Manufacturing , Michigan State , Gbs Global , Gbs Global Biopharma , Good Manufacturing , Cytokine Release Syndrome , Contract Research , Successful , 022 , Ilestones , Support , Value , Ciences , Nabled , Drug , Discovery , Platform ,